SQI Diagnostics updated the Company's clinical development progress for its three novel Covid-19 tests, highlighted by confirmation from the U.S. Food and Drug Administration (FDA) that Emergency Use Authorization (EUA) submission is acceptable for ...
SQI Diagnostics In today announced that it plans to release its financial and operational results for the three and six months ended March 31, 2018 at 5:00 p.m.